Cited by

• Pregnancies, abortions, and births among women with and without borderline personality disorder.

  De Genna NM, Feske U, Larkby C, Angiolieri T, Gold MA. De Genna NM, et al. Womens Health Issues. 2012 Jul-Aug;22(4):e371-7. doi: 10.1016/j.whi.2012.05.002. Womens Health Issues. 2012. PMID: 22749198 Free PMC article.
• Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders.

  Eleftheriou G, Zandonella Callegher R, Butera R, De Santis M, Cavaliere AF, Vecchio S, Pistelli A, Mangili G, Bondi E, Somaini L, Gallo M, Balestrieri M, Albert U. Eleftheriou G, et al. Int J Environ Res Public Health. 2023 Aug 11;20(16):6565. doi: 10.3390/ijerph20166565. Int J Environ Res Public Health. 2023. PMID: 37623151 Free PMC article.
• Equity in Policies Regarding Urine Drug Testing in Infants.

  Murosko D, Paul K, Barfield WD, Montoya-Williams D, Parga-Belinkie J. Murosko D, et al. Neoreviews. 2022 Nov 1;23(11):788-795. doi: 10.1542/neo.23-10-e788. Neoreviews. 2022. PMID: 36316251 Free PMC article.
• Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

  Convertino I, Sansone AC, Marino A, Galiulo MT, Mantarro S, Antonioli L, Fornai M, Blandizzi C, Tuccori M. Convertino I, et al. Drug Saf. 2016 Oct;39(10):903-24. doi: 10.1007/s40264-016-0435-8. Drug Saf. 2016. PMID: 27289228 Review.
• Outcomes of Implementing Routine Screening and Referrals for Perinatal Mood Disorders in an Integrated Multi-site Pediatric and Obstetric Setting.

  Puryear LJ, Nong YH, Correa NP, Cox K, Greeley CS. Puryear LJ, et al. Matern Child Health J. 2019 Oct;23(10):1292-1298. doi: 10.1007/s10995-019-02780-x. Matern Child Health J. 2019. PMID: 31222600